Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library

• Egile Nagusiak: Jie Feng (Egilea), Megan Weitner (Egilea), Wanliang Shi (Egilea), Shuo Zhang (Egilea), David Sullivan (Egilea), Ying Zhang (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2015-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Lyme disease is a leading vector-borne disease in the United States. Although the majority of Lyme patients can be cured with standard 2-4 week antibiotic treatment, 10%-20% of patients continue to suffer from prolonged post-treatment Lyme disease syndrome (PTLDS). While the cause for this is unclea...